Warning: The NCBI web site requires JavaScript to function. more...
High risk behaviors of injection drug users registered with harm reduction programme in Karachi, Pakistan.
Altaf A, Shah SA, Zaidi NA, Memon A, Nadeem-ur-Rehman, Wray N.
Harm Reduct J. 2007 Feb 10;4:7.
Related citations
HIV antibody seroprevalence and associated risk factors in sex workers, drug users, and prisoners in Sindh, Pakistan.
Baqi S, Nabi N, Hasan SN, Khan AJ, Pasha O, Kayani N, Haque RA, Haq-IU, Khurshid M, Fisher-Hoch S, Luby SP, McCormick JB.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 May 1;18(1):73-9.
Background demographics and risk behaviors of injecting drug users in Karachi, Pakistan.
Parviz S, Fatmi Z, Altaf A, McCormick JB, Fischer-Hoch S, Rahbar M, Luby S.
Int J Infect Dis. 2006 Sep;10(5):364-71. Epub 2006 Jun 21.
Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
Emmanuel F, Fatima M.
Int J Drug Policy. 2008 Apr;19 Suppl 1:S59-64. Epub 2008 Feb 20.
High prevalence of HIV infection among injection drug users (IDUs) in Hyderabad and Sukkur, Pakistan.
Altaf A, Saleem N, Abbas S, Muzaffar R.
J Pak Med Assoc. 2009 Mar;59(3):136-40.
Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection.
Panda S, Saha U, Pahari S, Nathan M, Poddar S, Neogi D, Sarkar M, Pal NK, Mahalanabis D.
Natl Med J India. 2002 May-Jun;15(3):128-34.
Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
Emmanuelli J, Desenclos JC.
Addiction. 2005 Nov;100(11):1690-700. Erratum in: Addiction. 2006 Apr;101(4):616.
HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: a cross-sectional survey.
Dumchev KV, Soldyshev R, Qian HZ, Zezyulin OO, Chandler SD, Slobodyanyuk P, Moroz L, Schumacher JE.
Harm Reduct J. 2009 Aug 23;6:23.
HIV-1 subtype A infection in a community of intravenous drug users in Pakistan.
Khan S, Rai MA, Khanani MR, Khan MN, Ali SH.
BMC Infect Dis. 2006 Nov 14;6:164.
Risk behaviours among HIV positive injecting drug users in Myanmar: a case control study.
Swe LA, Nyo KK, Rashid A.
Harm Reduct J. 2010 Jun 2;7:12.
Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N, Chkhartishvili N, Abutidze A, Gatserelia L, Sharvadze L.
Georgian Med News. 2008 Dec;(165):54-60.
Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Burt RD, Hagan H, Garfein RS, Sabin K, Weinbaum C, Thiede H.
J Urban Health. 2007 May;84(3):436-54.
Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment.
Todd CS, Nasir A, Stanekzai MR, Fiekert K, Rasuli MZ, Vlahov D, Strathdee SA.
Harm Reduct J. 2011 Aug 25;8:22.
Socio-economic and demographic factors associated with injecting drug use among drug users in Karachi, Pakistan.
Agha A, Parviz S, Younus M, Fatmi Z.
J Pak Med Assoc. 2003 Nov;53(11):511-6.
J Pak Med Assoc. 2006 Jan;56(1 Suppl 1):S55-60.
HIV risk in Karachi and Lahore, Pakistan: an emerging epidemic in injecting and commercial sex networks.
Bokhari A, Nizamani NM, Jackson DJ, Rehan NE, Rahman M, Muzaffar R, Mansoor S, Raza H, Qayum K, Girault P, Pisani E, Thaver I.
Int J STD AIDS. 2007 Jul;18(7):486-92.
Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC.
J Urban Health. 2008 May;85(3):309-22. Epub 2008 Mar 14.
Factors associated with an explosive HIV epidemic among injecting drug users in Sargodha, Pakistan.
Emmanuel F, Archibald C, Razaque A, Sandstrom P.
J Acquir Immune Defic Syndr. 2009 May 1;51(1):85-90.
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.
Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.
Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
Xia X, Luo J, Bai J, Yu R.
Public Health. 2008 Oct;122(10):990-1003. Epub 2008 May 19. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on